Lydia specialises in all types of transactions involving intellectual property, including licensing, collaboration agreements, joint ventures, consortium agreements, commercialisation agreements, monetisations and intellectual property aspects of corporate transactions and financings.
Lydia also advises on regulatory compliance issues including product classification, interactions with healthcare professionals, clinical trials, market access, supply chain requirements, marketing and pharmacovigilance.
Lydia has experience in a wide range of industries including life sciences, consumables, TMT, energy and infrastructure and finance.
- Recent Work
- advising on the £40m Apollo Therapeutics joint venture fund, a collaboration between GlaxoSmithKline, Johnson & Johnson Innovation and AstraZeneca with the technology transfer offices of Imperial College London, University College London and the University of Cambridge
- advising the MHRA’s Clinical Practice Research Datalink in connection with clinical data collection and licensing
- advising Concordia Healthcare on its agreement with Cinven to acquire Amdipharm Mercury Limited for approximately US$3.5bn. The firm advised on IP, pharmaceutical regulatory, pensions and employment law aspects in the UK and the Netherlands
- advising GlaxoSmithKline in connection with the first “open science” collaboration between industry and the Francis Crick Institute
- advising Eisai Co., Ltd on an agreement to license its in-house discovered selective phosphodiesterase 4 (PDE4) inhibitor E6005 to Roivant Sciences Ltd
- advising Fox Entertainment on its licensing arrangements with the BSkyB Group following the divestment of its Sky Italia and Sky Deutschland businesses
- advising a highly regulated global FMCG business on a review of its existing worldwide licensing arrangements followed by the design and implementation of a complex world-wide IP licensing income and taxation regime
- advising the UK government in connection with the IP aspects of sales of high value IP-heavy assets and complex cross-licensing arrangements in connection with public-private partnerships.
Lydia studied Law and French Law at University College London and Université Aix-Marseille II. Lydia teaches on the Oxford University Postgraduate Diploma in IP Law and Practice, is a contributing author to Globe Law and Business’ text “IP Issues in Corporate Transactions: A Practical Guide to the Treatment of Intellectual Property in Acquisitions and Investments” and speaks regularly on licensing issues.
Lydia has been named as a “rising star” by Managing Intellectual Property IP Stars, and a “Next Generation Lawyer” by Legal 500 and is singled out for her "deep technical understanding". She is also a member of the ABHI’s Legal Issues and Compliance Committee.